Sinovac Biotech, Ltd
Symbol: SVA (NASDAQ)
0.00
0.00 0.000
Company Description:
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
Key Stats
- Today's Open: $
- Today's High: $
- Today's Low: $
- Today's Volume:
- Yesterday Close: $
- Yesterday High: $
- Yesterday Low: $
- Yesterday Volume:
- Last Min Volume:
- Last Min High: $
- Last Min Low: $
- Last Min VWAP: $
Company Profile
- Name: Sinovac Biotech, Ltd
- Website: http://www.sinovac.com
- Listed Date: 2003-09-26
- Location: ,
- Market Status: Active
- CIK Number: 0001084201
- SIC Code:
- SIC description:
- Market Cap: $
- Round Lot: 100
- Outstanding Shares: 60.06M
- Asset Type: CS
RECENT FILINGS FOR SVA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-15 | SCHEDULE 13D/A | View |
| 2025-07-14 | SCHEDULE 13D/A | View |
| 2025-07-14 | SCHEDULE 13D/A | View |
| 2025-07-11 | SCHEDULE 13D/A | View |
| 2025-07-11 | 6-K | View |
| 2025-07-10 | 6-K | View |
| 2025-07-10 | 6-K | View |
| 2025-07-08 | 6-K | View |
| 2025-07-07 | SCHEDULE 13D/A | View |
| 2025-07-03 | SCHEDULE 13D/A | View |
| 2025-07-02 | 6-K | View |
| 2025-07-01 | SCHEDULE 13D/A | View |
| 2025-06-30 | 6-K | View |
| 2025-06-25 | 6-K | View |
| 2025-06-20 | SCHEDULE 13D/A | View |
| 2025-06-20 | 6-K | View |
| 2025-06-18 | 6-K | View |
| 2025-06-18 | 6-K | View |
| 2025-06-17 | SCHEDULE 13D/A | View |
| 2025-06-13 | SCHEDULE 13D/A | View |
Latest News on SVA